27 results on '"Huang, Xiao-Wu"'
Search Results
2. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
3. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
4. Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence
5. ZSAB-TOP: A phase 2 trial of tislelizumab (TIS) and ociperlimab (OCI) combined with gemcitabine and cisplatin (GemCis) as the first-line treatment for advanced biliary tract cancer (BTC).
6. Neutrophil extracellular traps in central nervous system (CNS) diseases
7. Testing and Analysis of Ultra-High Toughness Cementitious Composite-Confined Recycled Aggregate Concrete under Axial Compression Loading
8. Supplementary Figure from CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
9. Supplementary Data from CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
10. Supplementary Table from CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
11. 384 Systematic, antigen-agnostic discovery of tumor-reactive TCRs powered by repertoire-scale TCR gene synthesis and the use of banked allogeneic cancer cell lines
12. Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
13. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
14. Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver Transplantation
15. Application of circulating tumor DNA for prediction and surveillance of tumor recurrence after liver transplantation: A pilot study.
16. Adjuvant lenvatinib after radical resection in patients with hepatocellular carcinoma (HCC): Preliminary analysis of a prospective, multi-center, single-arm study.
17. Corrigendum to ‘Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence’ [J Hepatol 71 (2019) 1152-63]
18. Identification of competing endogenous RNA network in laryngeal squamous cell carcinoma.
19. CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
20. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma
21. Using anammox biofilms for rapid start-up of partial nitritation-anammox in integrated fixed-film activated sludge for autotrophic nitrogen removal
22. Use of a packed-bed biofilm reactor to achieve rapid formation of anammox biofilms for high-rate nitrogen removal
23. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma.
24. Sintilimab combined with bevacizumab biosimilar as a conversion therapy in potentially resectable intermediate-stage hepatocellular carcinoma (HCC): Updated results of a phase II trial.
25. The clinical efficacy and safety of sintilimab plus anlotinib for unresectable intrahepatic cholangiocarcinoma (ICC): A prospective, single-arm phase II study.
26. Enhanced production of short-chain fatty acids from sludge by thermal hydrolysis and acidogenic fermentation for organic resource recovery.
27. Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.